ACE-话题@MedSci

#ACE#

496篇内容 | 2894人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1656078, encodeId=691316560e8b4, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=武田与JCR Pharmaceuticals合作，将亨特综合征下一代治疗药物商业化, objectType=article, longId=218421, objectId=20732184217a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=20732184217a, replyNumber=0, likeNumber=82, createdTime=2021-11-30, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=20732184217a, moduleTitle=武田与JCR Pharmaceuticals合作，将亨特综合征下一代治疗药物商业化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=20732184217a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1656056, encodeId=c6a116560562b, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=EP Europace：全球专家定义如何评估房颤患者的护理质量, objectType=article, longId=210618, objectId=05282106189a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=05282106189a, replyNumber=0, likeNumber=74, createdTime=2021-11-29, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=05282106189a, moduleTitle=EP Europace：全球专家定义如何评估房颤患者的护理质量, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=05282106189a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1656079, encodeId=c12f16560e9a6, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=Rhizen Pharmaceuticals AG宣布在Tenalisib (RP6530)治疗局部晚期或转移性乳腺癌的II期研究中首次向患者给药, objectType=article, longId=218658, objectId=c75f218658a9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c75f218658a9, replyNumber=0, likeNumber=94, createdTime=2021-11-10, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c75f218658a9, moduleTitle=Rhizen Pharmaceuticals AG宣布在Tenalisib (RP6530)治疗局部晚期或转移性乳腺癌的II期研究中首次向患者给药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c75f218658a9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1656058, encodeId=824b16560589c, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=SpaceX星舰SN15超预期平稳着陆，曹原石墨烯研究再获新突破 | 一周科技导读, objectType=article, longId=211092, objectId=2edc2110923e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2edc2110923e, replyNumber=0, likeNumber=71, createdTime=2022-02-09, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2edc2110923e, moduleTitle=SpaceX星舰SN15超预期平稳着陆，曹原石墨烯研究再获新突破 | 一周科技导读, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2edc2110923e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1656063, encodeId=c84016560636f, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=Cardiovasc Diabetol：多因素干预对高危糖尿病肾病患者的MACE风险和死亡率的积极效益, objectType=article, longId=214526, objectId=60f3214526b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=60f3214526b7, replyNumber=0, likeNumber=71, createdTime=2021-10-03, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=60f3214526b7, moduleTitle=Cardiovasc Diabetol：多因素干预对高危糖尿病肾病患者的MACE风险和死亡率的积极效益, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=60f3214526b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1656037, encodeId=694c165603e10, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=Biol Trace Elem Res：经前综合征女性补锌可改善其经前综合征症状, objectType=article, longId=203228, objectId=8a9c20322829, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8a9c20322829, replyNumber=0, likeNumber=74, createdTime=2021-10-10, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8a9c20322829, moduleTitle=Biol Trace Elem Res：经前综合征女性补锌可改善其经前综合征症状, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8a9c20322829)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1656051, encodeId=a88c1656051df, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=JAMA子刊：60万人数据，ACEI类降压药会增加近8成精神分裂症风险！, objectType=article, longId=208625, objectId=27fe20862541, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=27fe20862541, replyNumber=0, likeNumber=63, createdTime=2021-12-19, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=27fe20862541, moduleTitle=JAMA子刊：60万人数据，ACEI类降压药会增加近8成精神分裂症风险！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=27fe20862541)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1656054, encodeId=f8cf1656054eb, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=JACC：ACEI类药物对终末期心力衰竭的心肌Ang代谢的影响, objectType=article, longId=209672, objectId=50b72096e255, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=50b72096e255, replyNumber=0, likeNumber=68, createdTime=2021-08-15, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=50b72096e255, moduleTitle=JACC：ACEI类药物对终末期心力衰竭的心肌Ang代谢的影响, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=50b72096e255)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1656039, encodeId=830a1656039c7, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=Hypertension：伴有白蛋白尿的高血压成人中使用ACE抑制剂或ARB的趋势, objectType=article, longId=203492, objectId=e99720349246, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e99720349246, replyNumber=0, likeNumber=72, createdTime=2021-08-12, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e99720349246, moduleTitle=Hypertension：伴有白蛋白尿的高血压成人中使用ACE抑制剂或ARB的趋势, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e99720349246)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1656070, encodeId=351e16560e04d, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=Liver Cnacer：mTOR抑制剂Temsirolimus联合索拉非尼治疗晚期肝细胞癌的疗效和安全性：II期临床研究, objectType=article, longId=216786, objectId=af4a216e8623, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=af4a216e8623, replyNumber=0, likeNumber=70, createdTime=2022-05-28, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=af4a216e8623, moduleTitle=Liver Cnacer：mTOR抑制剂Temsirolimus联合索拉非尼治疗晚期肝细胞癌的疗效和安全性：II期临床研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af4a216e8623)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1656055, encodeId=081416560555c, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=EHRA 2021｜LBCTs 先睹为快！RACE 3：持续性心房颤动和轻中度稳定型心力衰竭患者潜在疾病的靶向治疗的长期结果, objectType=article, longId=209993, objectId=e91d20999322, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e91d20999322, replyNumber=0, likeNumber=77, createdTime=2021-11-21, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e91d20999322, moduleTitle=EHRA 2021｜LBCTs 先睹为快！RACE 3：持续性心房颤动和轻中度稳定型心力衰竭患者潜在疾病的靶向治疗的长期结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e91d20999322)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1656062, encodeId=1cfb1656062ec, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=Hepatol Int: 前瞻性研究评估TACE单纯使用碘油对比TACE使用碘油联合可降解的淀粉微球(DSM)治疗肝细胞癌的疗效, objectType=article, longId=213475, objectId=ae672134e56d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae672134e56d, replyNumber=0, likeNumber=69, createdTime=2021-11-03, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae672134e56d, moduleTitle=Hepatol Int: 前瞻性研究评估TACE单纯使用碘油对比TACE使用碘油联合可降解的淀粉微球(DSM)治疗肝细胞癌的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ae672134e56d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1656067, encodeId=2cdc165606e71, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=JCEM：Tildacerfont对成人典型先天性肾上腺增生症患者的疗效与安全性研究, objectType=article, longId=215877, objectId=e4672158e7b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e4672158e7b5, replyNumber=0, likeNumber=50, createdTime=2022-01-11, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e4672158e7b5, moduleTitle=JCEM：Tildacerfont对成人典型先天性肾上腺增生症患者的疗效与安全性研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e4672158e7b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1656052, encodeId=f5ac1656052d4, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=Eur Heart J：预防性ACEi治疗与杜氏肌营养不良症患者总体生存率之间的关联, objectType=article, longId=208918, objectId=f491208918f8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f491208918f8, replyNumber=0, likeNumber=66, createdTime=2021-11-12, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f491208918f8, moduleTitle=Eur Heart J：预防性ACEi治疗与杜氏肌营养不良症患者总体生存率之间的关联, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f491208918f8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1656053, encodeId=6d1d1656053bc, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=默沙东联合Surface开展联合疗法研究，或将改善K药耐药性, objectType=article, longId=209545, objectId=c8ee20954549, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c8ee20954549, replyNumber=0, likeNumber=71, createdTime=2021-10-31, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c8ee20954549, moduleTitle=默沙东联合Surface开展联合疗法研究，或将改善K药耐药性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c8ee20954549)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1656047, encodeId=3919165604e7b, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=J Clin Oncol：新型选择性ER降解剂Elacestrant治疗ER+HER2-晚期乳腺癌的疗效和安全性, objectType=article, longId=206593, objectId=f30c2065934e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f30c2065934e, replyNumber=0, likeNumber=70, createdTime=2021-08-21, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f30c2065934e, moduleTitle=J Clin Oncol：新型选择性ER降解剂Elacestrant治疗ER+HER2-晚期乳腺癌的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f30c2065934e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1656034, encodeId=fdb81656034b7, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=Entos Pharmaceuticals已获进行COVID-19 DNA疫苗I期临床试验的资金支持, objectType=article, longId=202450, objectId=e82920245051, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e82920245051, replyNumber=0, likeNumber=74, createdTime=2021-10-07, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e82920245051, moduleTitle=Entos Pharmaceuticals已获进行COVID-19 DNA疫苗I期临床试验的资金支持, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e82920245051)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1656064, encodeId=18301656064df, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=心血管回顾性研究采用MACE作为结局哪些地方会被挑战 ?, objectType=article, longId=215014, objectId=119d21501478, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=119d21501478, replyNumber=0, likeNumber=70, createdTime=2022-05-01, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=119d21501478, moduleTitle=心血管回顾性研究采用MACE作为结局哪些地方会被挑战 ?, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=119d21501478)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1656032, encodeId=82311656032be, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=Circulation：MDM2介导的ACE2泛素化促进肺动脉高压进展, objectType=article, longId=201066, objectId=306b201066b9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=306b201066b9, replyNumber=0, likeNumber=91, createdTime=2021-04-27, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=306b201066b9, moduleTitle=Circulation：MDM2介导的ACE2泛素化促进肺动脉高压进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=306b201066b9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1656048, encodeId=bdc8165604801, content=<a href='/topic/show?id=2a011829d7' target=_blank style='color:#2F92EE;'>#ACE#</a>, objectTitle=Alzheimer's dementia： BACE1生物标志物可预测阿尔兹海默症, objectType=article, longId=206924, objectId=534f20692426, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=534f20692426, replyNumber=0, likeNumber=78, createdTime=2021-05-07, rootId=0, userName=shanyongle, userId=635024767990, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=534f20692426, moduleTitle=Alzheimer's dementia： BACE1生物标志物可预测阿尔兹海默症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=534f20692426)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ACE

2020-05-29

shanyongle (审核中...)

前往app查看评论内容

#ACE#

武田与JCR Pharmaceuticals合作，将亨特综合征下一代治疗药物商业化

2021-11-30

shanyongle (审核中...)

前往app查看评论内容

#ACE#

EP Europace：全球专家定义如何评估房颤患者的护理质量

2021-11-29

shanyongle (审核中...)

前往app查看评论内容

#ACE#

Rhizen Pharmaceuticals AG宣布在Tenalisib (RP6530)治疗局部晚期或转移性乳腺癌的II期研究中首次向患者给药

2021-11-10

shanyongle (审核中...)

前往app查看评论内容

#ACE#

SpaceX星舰SN15超预期平稳着陆，曹原石墨烯研究再获新突破 | 一周科技导读

2022-02-09

shanyongle (审核中...)

前往app查看评论内容

#ACE#

Cardiovasc Diabetol：多因素干预对高危糖尿病肾病患者的MACE风险和死亡率的积极效益

2021-10-03

shanyongle (审核中...)

前往app查看评论内容

#ACE#

Biol Trace Elem Res：经前综合征女性补锌可改善其经前综合征症状

2021-10-10

shanyongle (审核中...)

前往app查看评论内容

#ACE#

JAMA子刊：60万人数据，ACEI类降压药会增加近8成精神分裂症风险！

2021-12-19

shanyongle (审核中...)

前往app查看评论内容

#ACE#

JACC：ACEI类药物对终末期心力衰竭的心肌Ang代谢的影响

2021-08-15

shanyongle (审核中...)

前往app查看评论内容

#ACE#

Hypertension：伴有白蛋白尿的高血压成人中使用ACE抑制剂或ARB的趋势

2021-08-12

shanyongle (审核中...)

前往app查看评论内容

#ACE#

Liver Cnacer：mTOR抑制剂Temsirolimus联合索拉非尼治疗晚期肝细胞癌的疗效和安全性：II期临床研究

2022-05-28

shanyongle (审核中...)

前往app查看评论内容

#ACE#

EHRA 2021｜LBCTs 先睹为快！RACE 3：持续性心房颤动和轻中度稳定型心力衰竭患者潜在疾病的靶向治疗的长期结果

2021-11-21

shanyongle (审核中...)

前往app查看评论内容

#ACE#

Hepatol Int: 前瞻性研究评估TACE单纯使用碘油对比TACE使用碘油联合可降解的淀粉微球(DSM)治疗肝细胞癌的疗效

2021-11-03

shanyongle (审核中...)

前往app查看评论内容

#ACE#

JCEM：Tildacerfont对成人典型先天性肾上腺增生症患者的疗效与安全性研究

2022-01-11

shanyongle (审核中...)

前往app查看评论内容

#ACE#

Eur Heart J：预防性ACEi治疗与杜氏肌营养不良症患者总体生存率之间的关联

2021-11-12

shanyongle (审核中...)

前往app查看评论内容

#ACE#

默沙东联合Surface开展联合疗法研究，或将改善K药耐药性

2021-10-31

shanyongle (审核中...)

前往app查看评论内容

#ACE#

J Clin Oncol：新型选择性ER降解剂Elacestrant治疗ER+HER2-晚期乳腺癌的疗效和安全性

2021-08-21

shanyongle (审核中...)

前往app查看评论内容

#ACE#

Entos Pharmaceuticals已获进行COVID-19 DNA疫苗I期临床试验的资金支持

2021-10-07

shanyongle (审核中...)

前往app查看评论内容

#ACE#

心血管回顾性研究采用MACE作为结局哪些地方会被挑战 ?

2022-05-01

shanyongle (审核中...)

前往app查看评论内容

#ACE#

Circulation：MDM2介导的ACE2泛素化促进肺动脉高压进展

2021-04-27

shanyongle (审核中...)

前往app查看评论内容

#ACE#

Alzheimer's dementia： BACE1生物标志物可预测阿尔兹海默症

2021-05-07

科室
- - 订阅+
  - 更多科室
工具
服务